Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06454188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Study acronym: UP-SPOUT
StatusRecruiting
PhasePhase 4
Started2024-12-03
View on ClinicalTrials.gov ↗

Amendment history

2026-03-30
Study Status, Contacts/Locations v5
Primary completion date2026-12→2028-09
Completion date2026-12→2028-10
Start date2024-11-06→2024-12-03
Study sites4→5
2025-05-23
Study Status, Sponsor/Collaborators, Contacts/Locations v4
Study sites3→4
Collaborators+6 characters
AbbVie
2025-02-10
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-09→confirmed 2024-11-06
Study sites0→3
2024-08-23
Study Status v2
Start date2024-07→2024-09
2024-06-11
Study Status, Conditions v1
Re-verified, no change to tracked fields
2024-06-06
Original filing
A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)
Trial Details
NCT Number NCT06454188
Lead Sponsor CARE ARTHRITIS LTD.
Collaborators: AbbVie
Conditions Psoriatic Arthritis, Spondyloarthritis, Axial
Enrollment 100 participants
Start Date 2024-12-03
Primary Completion 2028-09 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-03